Dr. George Lewis is the founder and CEO of ZetrOZ Systems, a biomedical engineer who developed the company's Sustained Acoustic Medicine (sam®) technology. His work focuses on wearable bioelectronic devices, particularly miniaturized ultrasound systems, for treating acute and chronic musculoskeletal conditions like arthritis and injuries. Lewis has a Ph.D. from Cornell University and has filed over 60 global patents related to his work.
• Education: Lewis graduated summa cum laude with a degree in biomedical engineering from the University of Miami and earned his doctorate from Cornell University.
• Career: He founded ZetrOZ Systems in 2007 and has spent 19 years developing and commercializing wearable bioelectronic devices. He is also a former Presidential Life Science Fellow and National Science Foundation Fellow.
• Key Innovation: Lewis is the inventor of Sustained Acoustic Medicine (sam®), a proprietary, miniaturized ultrasound technology used in ZetrOZ's FDA-cleared wearable devices like the sam® X1 and sam® 2.0.
• Purpose of Technology: The sam® technology is designed to accelerate the natural healing process, increase circulation, and relieve pain from musculoskeletal issues through sustained, long-duration ultrasound treatment.
• Applications: ZetrOZ Systems has seen its technology used in various fields, including professional sports, military, and general healthcare for conditions such as tendinitis, chronic injuries, and osteoarthritis.